Fresenius Medical Care AG & Co. KGaA (FMS) Balance Sheet

The stability of the debt-to-equity ratio appears to reflect offsetting movements, with asset shrinkage and equity swings driven partly by retained earnings volatility rather than deliberate deleveraging. The shift in retained earnings reported in 2025Q4 suggests that discrete accounting items may be distorting the trend. Investors should monitor whether the asset base contraction reflects divestitures under the FMG25 program or underlying operating weakness.

A flat debt stack combined with declining cash implies that net leverage has drifted upward even though the gross ratio appears stable. The reported debt-to-equity of 0.79 sits inconsistently against historical leverage norms for FMS, which warrants verification before drawing firm conclusions about interest rate sensitivity. Refinancing exposure should be examined against the maturity schedule, which is not provided in the supplied data.

A current ratio approaching 1.0 indicates a thinner buffer against short-term obligations, particularly given cash of only $1.1B. This trend may reflect growing payables or accrued labor costs consistent with the margin pressure seen in the income statement. Analysts should monitor whether working capital management can absorb further pressure without requiring external financing.

The high goodwill share reflects the acquisition-driven history of the dialysis network and implies meaningful impairment exposure if clinic-level returns continue to compress. The stable PPE base is consistent with a mature, fixed-cost clinic footprint rather than heavy recent reinvestment. Goodwill sensitivity should be weighed against the divestiture program, as any impairment would reduce equity directly.